Koren G. Discontinuation syndrome following late pregnancy exposure to antidepressants. Arch Pediatr Adolesc Med 2004;158:307– 308.
93.
Kumar C, McIvor RJ, Davies T, et al. Estrogen administration does not reduce the rate of recurrence of affective psychosis after childbirth. J Clin Psychiatry 2003;64:112–118.
94.
Wisner KL, Perel JM, Peindl KS, et al. Prevention of recurrent postpartum depression. J Clin Psychiatry 2001;62:82–86.
95.
Cooper R, Mishra G, Hardy R, et al. Hysterectomy and subsequent psychological health: findings from a British birth cohort study. J Affect Disord 2009;115:122–130.
96.
Bhattacharya SM, Jha A. A comparison of health-related quality of life (HRQOL) after natural and surgical menopause. Maturitas 2010;66:431–434.
97.
Cabness J. The psychosocial dimensions of hysterectomy: private places and the inner spaces of women at midlife. Soc Work Health Care 2010;49:211–226.
98.
McKinlay JB, McKinlay SM, Brambilla DJ. Health status and utilization behavior associated with menopause. Am J Epidemiol 1987;125:110–121.
99.
Hamilton JA. Psychobiology in context: reproductive-related events in men’s and women’s lives (review of motherhood and mental illness). Contemp Psych 1984;3:12–16.
100.
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–333.
101.
Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 2004;291:1701– 1712.
102.
Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839– 1854.
103.
Cohen LS, Soares CN, Poitras JR, et al. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry 2003;160:1519–1522.
104.
Kugaya A, Epperson CN, Zoghbi S, et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in post-menopausal women. Am J Psychiatry 2003;160:1522–1524.
105.
Soares CN, Almeida OP, Joffe H, et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58:529–534.
106.